Q/C Technologies, Inc. SEC filings QCLS

Q/C Technologies, Inc. has 604 filings in SEC EDGAR's recent list, going back to Mar 23, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (material agreement, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Apr 29, 2026 Dec 31, 2025
10-K Annual report Apr 15, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 21, 2025 Dec 31, 2024
10-K Annual report Apr 11, 2025 Dec 31, 2024
ARS Annual report to shareholders Nov 1, 2024 Dec 31, 2023
10-K Annual report Apr 1, 2024 Dec 31, 2023
ARS Annual report to shareholders Jun 30, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
10-K/A Amended annual report Oct 21, 2020 Dec 31, 2019
10-K Annual report Mar 25, 2020 Dec 31, 2019
10-K Annual report Apr 1, 2019 Dec 31, 2018
10-K/A Amended annual report Jul 13, 2018 Dec 31, 2017
10-K Annual report Apr 3, 2018 Dec 31, 2017
10-K/A Amended annual report Apr 18, 2017 Dec 31, 2016
10-K Annual report Apr 11, 2017 Dec 31, 2016
10-K/A Amended annual report Mar 30, 2016 Dec 31, 2015
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K Annual report Mar 23, 2015 Dec 31, 2014
10-K Annual report Mar 28, 2014 Dec 31, 2013

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
QCLS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1321834
Former names
Q/C TECHNOLOGIES, INC. (until Oct 2, 2026); TNF Pharmaceuticals, Inc. (until Sep 10, 2025); MyMD Pharmaceuticals, Inc. (until Jul 1, 2024); Akers Biosciences, Inc. (until Apr 16, 2021); Akers Biosciences Inc (until Apr 11, 2017)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.